Patent · US Active

Therapeutic use of tetrathiomolybdate

US10478455B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

UCL Business Ltd · GB

Inventors

Mervyn Singer · London, GB
John Francis Martin · Danvers, US
Alex Peter Dyson · Westminster, GB

Key dates

Filing date	Sep 28, 2012
Grant date	Nov 19, 2019
Priority date	—
Expiry date	Sep 28, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K33/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Tetrathiomolybdate is for use in therapy of a condition requiring reduced metabolism of an organ or whole body, e.g. myocardial infection, stroke or ischaemia-reperfusion injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.